17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Hydroxyprogesterone caproate.
3-N-Butylphthalide
The risk or severity of adverse effects can be increased when Butylphthalide is combined with Apixaban.
Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Apixaban.
Advertisement
Abciximab
The risk or severity of adverse effects can be increased when Abciximab is combined with Apixaban.
Abiraterone
The serum concentration of Apixaban can be increased when it is combined with Abiraterone.
Aceclofenac
Aceclofenac may increase the anticoagulant activities of Apixaban.
Advertisement
Acemetacin
The risk or severity of bleeding can be increased when Apixaban is combined with Acemetacin.
Acenocoumarol
Apixaban may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Apixaban.
Advertisement
Adapalene
Adapalene may increase the anticoagulant activities of Apixaban.
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Apixaban.
Allylestrenol
The therapeutic efficacy of Apixaban can be decreased when used in combination with Allylestrenol.
Alminoprofen
Alminoprofen may increase the anticoagulant activities of Apixaban.
Aloxiprin
Aloxiprin may increase the anticoagulant activities of Apixaban.
alpha Tocopherol
Vitamin E may increase the anticoagulant activities of Apixaban.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Apixaban.
Alprostadil
The risk or severity of adverse effects can be increased when Alprostadil is combined with Apixaban.
Alteplase
Alteplase may increase the anticoagulant activities of Apixaban.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Apixaban.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Apixaban.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Apixaban.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Apixaban.
Aminosalicylic Acid
Aminosalicylic Acid may increase the anticoagulant activities of Apixaban.
Amiodarone
The serum concentration of Apixaban can be increased when it is combined with Amiodarone.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Apixaban.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Apixaban.
Anagrelide
The risk or severity of adverse effects can be increased when Anagrelide is combined with Apixaban.
Ancrod
Apixaban may increase the anticoagulant activities of Ancrod.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Apixaban.
Anistreplase
Anistreplase may increase the anticoagulant activities of Apixaban.
Antipyrine
Antipyrine may increase the anticoagulant activities of Apixaban.
Antithrombin III
Apixaban may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Apixaban may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Apixaban can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may increase the anticoagulant activities of Apixaban.
Apremilast
Apremilast may increase the anticoagulant activities of Apixaban.
Aprepitant
The serum concentration of Apixaban can be increased when it is combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Apixaban can be decreased when used in combination with Aprotinin.
Ardeparin
Apixaban may increase the anticoagulant activities of Ardeparin.
Argatroban
The risk or severity of adverse effects can be increased when Argatroban is combined with Apixaban.
Argatroban Anhydrous
The risk or severity of adverse effects can be increased when Argatroban is combined with Apixaban.
Armodafinil
The metabolism of Apixaban can be decreased when combined with Armodafinil.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Apixaban.
Astaxanthin
Astaxanthin may increase the anticoagulant activities of Apixaban.
Atazanavir
The serum concentration of Apixaban can be increased when it is combined with Atazanavir.
Atomoxetine
The serum concentration of Apixaban can be increased when it is combined with Atomoxetine.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Apixaban.
azficel-T
The risk or severity of adverse effects can be increased when Apixaban is combined with Azficel-T.
Azithromycin
The metabolism of Apixaban can be decreased when combined with Azithromycin.
Balsalazide
Balsalazide may increase the anticoagulant activities of Apixaban.
Becaplermin
Apixaban may increase the anticoagulant activities of Becaplermin.
Bemiparin
Bemiparin may increase the anticoagulant activities of Apixaban.
Benzydamine
Benzydamine may increase the anticoagulant activities of Apixaban.
Bivalirudin
Apixaban may increase the anticoagulant activities of Bivalirudin.
Boceprevir
The serum concentration of Apixaban can be decreased when it is combined with Boceprevir.
Bortezomib
The serum concentration of Apixaban can be increased when it is combined with Bortezomib.
Bosentan
The serum concentration of Apixaban can be decreased when it is combined with Bosentan.
Bromfenac
Bromfenac may increase the anticoagulant activities of Apixaban.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Apixaban.
Bufexamac
Bufexamac may increase the anticoagulant activities of Apixaban.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Apixaban.
Caffeine
The metabolism of Apixaban can be decreased when combined with Caffeine.
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Apixaban.
Capecitabine
The metabolism of Apixaban can be decreased when combined with Capecitabine.
Carbamazepine
The serum concentration of Apixaban can be decreased when it is combined with Carbamazepine.
Carprofen
Carprofen may increase the anticoagulant activities of Apixaban.
Celecoxib
Celecoxib may increase the anticoagulant activities of Apixaban.
Ceritinib
The serum concentration of Apixaban can be increased when it is combined with Ceritinib.
Certoparin
Apixaban may increase the anticoagulant activities of Certoparin.
Chloramphenicol
The metabolism of Apixaban can be decreased when combined with Chloramphenicol.
Chloroquine
Chloroquine may increase the anticoagulant activities of Apixaban.
Chlorotrianisene
The serum concentration of Chlorotrianisene can be decreased when it is combined with Apixaban.
Cholecalciferol
The metabolism of Apixaban can be decreased when combined with Cholecalciferol.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may increase the anticoagulant activities of Apixaban.
Cilostazol
The risk or severity of adverse effects can be increased when Cilostazol is combined with Apixaban.
Cimetidine
The metabolism of Apixaban can be decreased when combined with Cimetidine.
Citalopram
The metabolism of Apixaban can be decreased when combined with Citalopram.
Citric Acid
Apixaban may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Apixaban may increase the anticoagulant activities of Citric Acid.
Clarithromycin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Apixaban.
Clemastine
The serum concentration of Apixaban can be increased when it is combined with Clemastine.
Clofezone
The metabolism of Apixaban can be decreased when combined with Rabeprazole.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Apixaban.
Clonixin
Clonixin may increase the anticoagulant activities of Apixaban.
Clopidogrel
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Apixaban.
Clotrimazole
The serum concentration of Apixaban can be increased when it is combined with Clotrimazole.
Cobicistat
The serum concentration of Apixaban can be increased when it is combined with Cobicistat.
COLLAGENASE
The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Apixaban.
Crisaborole
The metabolism of Apixaban can be decreased when combined with Crisaborole.
Crizotinib
The serum concentration of Apixaban can be increased when it is combined with Crizotinib.
Curcumin
Curcumin may increase the anticoagulant activities of Apixaban.
Cyclobenzaprine
The serum concentration of Cyclobenzaprine can be increased when it is combined with Apixaban.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Apixaban is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Apixaban is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Apixaban.
Cyproterone Acetate
The serum concentration of Apixaban can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
Apixaban may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Apixaban can be decreased when it is combined with Dabrafenib.
Dalteparin
Apixaban may increase the anticoagulant activities of Dalteparin.
Danaparoid
Apixaban may increase the anticoagulant activities of Danaparoid.
Darunavir
The serum concentration of Apixaban can be increased when it is combined with Darunavir.
Dasatinib
Dasatinib may increase the anticoagulant activities of Apixaban.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Apixaban.
Deferasirox
The serum concentration of Apixaban can be decreased when it is combined with Deferasirox.
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Apixaban.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Apixaban.
Deoxycholate
The risk or severity of adverse effects can be increased when Apixaban is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Apixaban is combined with Deoxycholic Acid.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Apixaban.
Desirudin
Apixaban may increase the anticoagulant activities of Desirudin.
Desogestrel
The therapeutic efficacy of Apixaban can be decreased when used in combination with Desogestrel.
Dextran
Apixaban may increase the anticoagulant activities of Dextran.
Dextran 40
Apixaban may increase the anticoagulant activities of Dextran 40.
Dextran 70
Apixaban may increase the anticoagulant activities of Dextran 70.
Dextran 75
Apixaban may increase the anticoagulant activities of Dextran 75.
Diclofenac
Diclofenac may increase the anticoagulant activities of Apixaban.
Dicumarol
Apixaban may increase the anticoagulant activities of Dicoumarol.
Dienestrol
The serum concentration of Dienestrol can be decreased when it is combined with Apixaban.
Dienogest
The therapeutic efficacy of Apixaban can be decreased when used in combination with Dienogest.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Apixaban.
Diflunisal
Diflunisal may increase the anticoagulant activities of Apixaban.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Apixaban.
Dihydroergotamine
The serum concentration of Apixaban can be increased when it is combined with Dihydroergotamine.
Diltiazem
The serum concentration of Apixaban can be increased when it is combined with Diltiazem.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Apixaban.
Dipyrone
Metamizole may increase the anticoagulant activities of Apixaban.
Dothiepin
The metabolism of Apixaban can be decreased when combined with Dosulepin.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Apixaban.
Doxycycline
The serum concentration of Apixaban can be increased when it is combined with Doxycycline.
Doxycycline Anhydrous
The serum concentration of Apixaban can be increased when it is combined with Doxycycline.
Dronedarone
The serum concentration of Apixaban can be increased when it is combined with Dronedarone.
Drotrecogin Alfa
Drotrecogin alfa may increase the anticoagulant activities of Apixaban.
Droxicam
Droxicam may increase the anticoagulant activities of Apixaban.
Dydrogesterone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Dydrogesterone.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Apixaban.
Edetic Acid
Apixaban may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Apixaban may increase the anticoagulant activities of Edoxaban.
Efavirenz
The metabolism of Apixaban can be decreased when combined with Efavirenz.
Eltrombopag
The serum concentration of Apixaban can be increased when it is combined with Eltrombopag.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Apixaban.
Enoxaparin
Apixaban may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Apixaban may increase the anticoagulant activities of Enoxaparin.
Enzalutamide
The serum concentration of Apixaban can be decreased when it is combined with Enzalutamide.
Epinastine
The risk or severity of adverse effects can be increased when Epinastine is combined with Apixaban.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Apixaban.
Eptifibatide
The risk or severity of adverse effects can be increased when Eptifibatide is combined with Apixaban.
Equol, (-)-
Equol may decrease the anticoagulant activities of Apixaban.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Apixaban.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Apixaban.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Apixaban.
Erythromycin
The serum concentration of Apixaban can be increased when it is combined with Erythromycin.
Eslicarbazepine Acetate
The metabolism of Apixaban can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Apixaban can be decreased when combined with Esomeprazole.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Apixaban.
Estradiol acetate
Estradiol acetate may decrease the anticoagulant activities of Apixaban.
Estradiol Cypionate
Estradiol cypionate may decrease the anticoagulant activities of Apixaban.
Estradiol Valerate
Estradiol valerate may decrease the anticoagulant activities of Apixaban.
Estramustine
The serum concentration of Estramustine can be decreased when it is combined with Apixaban.
Estriol
Estriol may decrease the anticoagulant activities of Apixaban.
Estrogens, Conjugated (USP)
The serum concentration of Conjugated estrogens can be decreased when it is combined with Apixaban.
Estrogens, Esterified (USP)
The serum concentration of Estrogens, esterified can be decreased when it is combined with Apixaban.
Estrone
Estrone may decrease the anticoagulant activities of Apixaban.
Etanercept
Etanercept may increase the anticoagulant activities of Apixaban.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Apixaban.
Ethylenediaminetetraacetate
Apixaban may increase the anticoagulant activities of Edetic Acid.
Ethynodiol
The therapeutic efficacy of Apixaban can be decreased when used in combination with Ethynodiol.
Etodolac
Etodolac may increase the anticoagulant activities of Apixaban.
Etofenamate
Etofenamate may increase the anticoagulant activities of Apixaban.
Etonogestrel
The therapeutic efficacy of Apixaban can be decreased when used in combination with Etonogestrel.
Etoricoxib
Etoricoxib may increase the anticoagulant activities of Apixaban.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Apixaban.
Evening primrose oil
Evening primrose oil may increase the anticoagulant activities of Apixaban.
Felbinac
Felbinac may increase the anticoagulant activities of Apixaban.
Felodipine
The metabolism of Apixaban can be decreased when combined with Felodipine.
Fenbufen
Fenbufen may increase the anticoagulant activities of Apixaban.
Fenoprofen
Fenoprofen may increase the anticoagulant activities of Apixaban.
Ferulic Acid
Apixaban may increase the anticoagulant activities of Ferulic acid.
Fibrinolysis Inhibitor
The therapeutic efficacy of Apixaban can be decreased when used in combination with Aprotinin.
Floctafenine
Floctafenine may increase the anticoagulant activities of Apixaban.
Floxuridine
The metabolism of Apixaban can be decreased when combined with Floxuridine.
Fluconazole
The serum concentration of Apixaban can be increased when it is combined with Fluconazole.
Fluindione
Apixaban may increase the anticoagulant activities of Fluindione.
Fluorouracil
The metabolism of Apixaban can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Apixaban can be decreased when combined with Fluoxetine.
Flurbiprofen
Flurbiprofen may increase the anticoagulant activities of Apixaban.
Fluvastatin
The metabolism of Apixaban can be decreased when combined with Fluvastatin.
Fluvoxamine
The serum concentration of Apixaban can be increased when it is combined with Fluvoxamine.
Fondaparinux
Apixaban may increase the anticoagulant activities of Fondaparinux.
Fondaparinux sodium
Apixaban may increase the anticoagulant activities of Fondaparinux sodium.
Fosamprenavir
The serum concentration of Apixaban can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Apixaban can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Apixaban can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Apixaban can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Apixaban can be increased when it is combined with Fusidic Acid.
Garlic Allergenic Extract
The serum concentration of Apixaban can be decreased when it is combined with Garlic.
Gemfibrozil
The metabolism of Apixaban can be decreased when combined with Gemfibrozil.
Genistein
Genistein may decrease the anticoagulant activities of Apixaban.
Gestodene
The therapeutic efficacy of Apixaban can be decreased when used in combination with Gestodene.
Gestrinone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Gestrinone.
Hemin
Hemin may increase the anticoagulant activities of Apixaban.
Heparin
Apixaban may increase the anticoagulant activities of Heparin.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Apixaban can be decreased when used in combination with Hydroxyprogesterone caproate.
Hydroxytyrosol
The risk or severity of adverse effects can be increased when Hydroxytyrosol is combined with Apixaban.
Hypoxis hemerocallidea root extract
The serum concentration of Apixaban can be decreased when it is combined with St. John's Wort.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Apixaban is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Apixaban.
Ibuprofen
Ibuprofen may increase the anticoagulant activities of Apixaban.
Icatibant
Icatibant may increase the anticoagulant activities of Apixaban.
Icosapent Ethyl
The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Apixaban.
Idelalisib
The serum concentration of Apixaban can be increased when it is combined with Idelalisib.
Ifenprodil
The risk or severity of adverse effects can be increased when Ifenprodil is combined with Apixaban.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Apixaban.
Imatinib
The serum concentration of Apixaban can be increased when it is combined with Imatinib.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Apixaban.
Indinavir
The serum concentration of Apixaban can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Apixaban can be increased when it is combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Apixaban.
Indomethacin
Indomethacin may increase the anticoagulant activities of Apixaban.
Irbesartan
The metabolism of Apixaban can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Apixaban can be increased when it is combined with Isavuconazole.
Isavuconazonium
The serum concentration of Apixaban can be increased when it is combined with Isavuconazonium.
Isoniazid
The metabolism of Apixaban can be decreased when combined with Isoniazid.
Isradipine
The serum concentration of Apixaban can be increased when it is combined with Isradipine.
Itraconazole
The serum concentration of Apixaban can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Apixaban can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may increase the anticoagulant activities of Apixaban.
Ketanserin
The risk or severity of adverse effects can be increased when Ketanserin is combined with Apixaban.
Ketoconazole
The serum concentration of Apixaban can be increased when it is combined with Ketoconazole.
Ketoprofen
Ketoprofen may increase the anticoagulant activities of Apixaban.
Ketorolac
Ketorolac may increase the anticoagulant activities of Apixaban.
Lapatinib
The metabolism of Apixaban can be decreased when combined with Lapatinib.
Leflunomide
The metabolism of Apixaban can be decreased when combined with Leflunomide.
Lepirudin
Apixaban may increase the anticoagulant activities of Lepirudin.
Levonorgestrel
The therapeutic efficacy of Apixaban can be decreased when used in combination with Levonorgestrel.
Lidocaine
The metabolism of Apixaban can be decreased when combined with Lidocaine.
Limonene, (+)-
(4R)-limonene may increase the anticoagulant activities of Apixaban.
Lopinavir
The serum concentration of Apixaban can be increased when it is combined with Lopinavir.
Lornoxicam
Lornoxicam may increase the anticoagulant activities of Apixaban.
Losartan
The metabolism of Apixaban can be decreased when combined with Losartan.
Lovastatin
The serum concentration of Apixaban can be increased when it is combined with Lovastatin.
Loxoprofen
Loxoprofen may increase the anticoagulant activities of Apixaban.
Luliconazole
The serum concentration of Apixaban can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Apixaban can be decreased when it is combined with Lumacaftor.
Magnesium Salicylate
Magnesium salicylate may increase the anticoagulant activities of Apixaban.
Manidipine
The metabolism of Apixaban can be decreased when combined with Manidipine.
Masoprocol
Masoprocol may increase the anticoagulant activities of Apixaban.
Meclofenamate
Meclofenamic acid may increase the anticoagulant activities of Apixaban.
Meclofenamic Acid
Meclofenamic acid may increase the anticoagulant activities of Apixaban.
Medrogestone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Apixaban can be decreased when used in combination with Medroxyprogesterone acetate.
Mefenamic Acid
Mefenamic acid may increase the anticoagulant activities of Apixaban.
Megestrol Acetate
The therapeutic efficacy of Apixaban can be decreased when used in combination with Megestrol acetate.
Meloxicam
Meloxicam may increase the anticoagulant activities of Apixaban.
Meperidine
The risk or severity of adverse effects can be increased when Apixaban is combined with Pethidine.
Mesalamine
Mesalazine may increase the anticoagulant activities of Apixaban.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Apixaban.
Methyl Salicylate
Methyl salicylate may increase the anticoagulant activities of Apixaban.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Apixaban.
Mexiletine
The metabolism of Apixaban can be decreased when combined with Mexiletine.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Apixaban.
Midostaurin
The metabolism of Apixaban can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Apixaban can be increased when it is combined with Mifepristone.
Milrinone
The risk or severity of adverse effects can be increased when Milrinone is combined with Apixaban.
Mirtazapine
The serum concentration of Mirtazapine can be increased when it is combined with Apixaban.
Mitotane
The serum concentration of Apixaban can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Apixaban can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Apixaban can be decreased when combined with Modafinil.
MYCOPHENOLATE
Mycophenolic acid may increase the anticoagulant activities of Apixaban.
Mycophenolate Mofetil
Mycophenolate mofetil may increase the anticoagulant activities of Apixaban.
Mycophenolic Acid
Mycophenolic acid may increase the anticoagulant activities of Apixaban.
Nabumetone
Nabumetone may increase the anticoagulant activities of Apixaban.
Nadroparin
Apixaban may increase the anticoagulant activities of Nadroparin.
Naftifine
Naftifine may increase the anticoagulant activities of Apixaban.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Apixaban.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Apixaban.
Nelfinavir
The serum concentration of Apixaban can be increased when it is combined with Nelfinavir.
Nepafenac
Nepafenac may increase the anticoagulant activities of Apixaban.
Netupitant
The serum concentration of Apixaban can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Apixaban can be increased when it is combined with Nevirapine.
Nicardipine
The metabolism of Apixaban can be decreased when combined with Nicardipine.
Niflumic Acid
Niflumic Acid may increase the anticoagulant activities of Apixaban.
Nilotinib
The serum concentration of Apixaban can be increased when it is combined with Nilotinib.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Apixaban.
Nintedanib
The risk or severity of adverse effects can be increased when Apixaban is combined with Nintedanib.
Nomegestrol
The therapeutic efficacy of Apixaban can be decreased when used in combination with Nomegestrol.
Norethindrone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Norethisterone.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Apixaban.
Obinutuzumab
The risk or severity of adverse effects can be increased when Apixaban is combined with Obinutuzumab.
Oenothera biennis seed extract
Evening primrose oil may increase the anticoagulant activities of Apixaban.
Olaparib
The serum concentration of Apixaban can be increased when it is combined with Olaparib.
Olopatadine
Olopatadine may increase the anticoagulant activities of Apixaban.
Olsalazine
Olsalazine may increase the anticoagulant activities of Apixaban.
Omacetaxine Mepesuccinate
The risk or severity of bleeding can be increased when Apixaban is combined with Omacetaxine mepesuccinate.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the anticoagulant activities of Apixaban.
Omeprazole
The metabolism of Apixaban can be decreased when combined with Omeprazole.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Apixaban.
Osimertinib
The serum concentration of Apixaban can be increased when it is combined with Osimertinib.
Oxaprozin
Oxaprozin may increase the anticoagulant activities of Apixaban.
Oxyphenbutazone
Oxyphenbutazone may increase the anticoagulant activities of Apixaban.
Palbociclib
The serum concentration of Apixaban can be increased when it is combined with Palbociclib.
Pantoprazole
The metabolism of Apixaban can be decreased when combined with Pantoprazole.
Parecoxib
Parecoxib may increase the anticoagulant activities of Apixaban.
Parnaparin
Parnaparin may increase the anticoagulant activities of Apixaban.
Parthenolide
Parthenolide may increase the anticoagulant activities of Apixaban.
Peginterferon Alfa-2b
The serum concentration of Apixaban can be increased when it is combined with Peginterferon alfa-2b.
Pentaerythritol Tetranitrate
Apixaban may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentobarbital
The serum concentration of Apixaban can be decreased when it is combined with Pentobarbital.
Pentosan Polysulfate
Apixaban may increase the anticoagulant activities of Pentosan Polysulfate.
Pentoxifylline
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Apixaban.
Phenindione
Apixaban may increase the anticoagulant activities of Phenindione.
Phenobarbital
The serum concentration of Apixaban can be decreased when it is combined with Phenobarbital.
Phenprocoumon
Apixaban may increase the anticoagulant activities of Phenprocoumon.
Phenylbutazone
Phenylbutazone may increase the anticoagulant activities of Apixaban.
Phenytoin
The serum concentration of Apixaban can be decreased when it is combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the anticoagulant activities of Apixaban.
Pimecrolimus
Pimecrolimus may increase the anticoagulant activities of Apixaban.
Pioglitazone
The metabolism of Apixaban can be decreased when combined with Pioglitazone.
Pirfenidone
Pirfenidone may increase the anticoagulant activities of Apixaban.
Piroxicam
Piroxicam may increase the anticoagulant activities of Apixaban.
Piroxicam-Beta-Cyclodextrin
Piroxicam may increase the anticoagulant activities of Apixaban.
Plasmin
Fibrinolysin may increase the anticoagulant activities of Apixaban.
Polyestradiol Phosphate
Polyestradiol phosphate may decrease the anticoagulant activities of Apixaban.
Posaconazole
The serum concentration of Apixaban can be increased when it is combined with Posaconazole.
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Apixaban.
Primidone
The serum concentration of Apixaban can be decreased when it is combined with Primidone.
Progesterone
The therapeutic efficacy of Apixaban can be decreased when used in combination with Progesterone.
Promestriene
Promestriene may decrease the anticoagulant activities of Apixaban.
protein C, human
Apixaban may increase the anticoagulant activities of Protein C.
protein S, human
Apixaban may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Apixaban may increase the anticoagulant activities of Protocatechualdehyde.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Apixaban.
Pyrimethamine
The metabolism of Apixaban can be decreased when combined with Pyrimethamine.
Quinestrol
Quinestrol may decrease the anticoagulant activities of Apixaban.
Quinine
The metabolism of Apixaban can be decreased when combined with Quinine.
Rabeprazole
The metabolism of Apixaban can be decreased when combined with Rabeprazole.
Ranolazine
The serum concentration of Apixaban can be increased when it is combined with Ranolazine.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Apixaban.
Reteplase
Reteplase may increase the anticoagulant activities of Apixaban.
Reviparin
Apixaban may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Apixaban may increase the anticoagulant activities of Reviparin.
Rifabutin
The serum concentration of Apixaban can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Apixaban can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Apixaban can be decreased when it is combined with Rifapentine.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Apixaban.
Rivaroxaban
Apixaban may increase the anticoagulant activities of Rivaroxaban.
Rofecoxib
Rofecoxib may increase the anticoagulant activities of Apixaban.
Rolapitant
The serum concentration of Apixaban can be increased when it is combined with Rolapitant.
Ropinirole
The metabolism of Apixaban can be decreased when combined with Ropinirole.
Rosiglitazone
Rosiglitazone may increase the anticoagulant activities of Apixaban.
Rucaparib
The serum concentration of Apixaban can be increased when it is combined with Rucaparib.
Salicylamide
Salicylamide may increase the anticoagulant activities of Apixaban.
Salicylic Acid
Salicylic acid may increase the anticoagulant activities of Apixaban.
Salsalate
Salsalate may increase the anticoagulant activities of Apixaban.
Saquinavir
The serum concentration of Apixaban can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Apixaban can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Apixaban can be decreased when used in combination with Sarilumab.
Secobarbital
The metabolism of Apixaban can be increased when combined with Secobarbital.
Selexipag
Selexipag may increase the anticoagulant activities of Apixaban.
Serratiopeptidase
Serrapeptase may increase the anticoagulant activities of Apixaban.
Sertraline
The metabolism of Apixaban can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Apixaban.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Apixaban.
Siltuximab
The serum concentration of Apixaban can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Apixaban can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Apixaban.
Sorafenib
The metabolism of Apixaban can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Apixaban can be decreased when it is combined with St. John's Wort.
Streptokinase
Streptokinase may increase the anticoagulant activities of Apixaban.
Sugammadex
Sugammadex may increase the anticoagulant activities of Apixaban.
Sulfadiazine
The metabolism of Apixaban can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Apixaban can be decreased when combined with Sulfamethoxazole.
Sulfasalazine
Sulfasalazine may increase the anticoagulant activities of Apixaban.
Sulfisoxazole
The serum concentration of Apixaban can be increased when it is combined with Sulfisoxazole.
Sulindac
Sulindac may increase the anticoagulant activities of Apixaban.
Suprofen
Suprofen may increase the anticoagulant activities of Apixaban.
synthetic conjugated estrogens, A
The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Apixaban.
synthetic conjugated estrogens, B
Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Apixaban.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Apixaban.
Tamoxifen
The metabolism of Apixaban can be decreased when combined with Tamoxifen.
Telaprevir
The serum concentration of Apixaban can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Apixaban can be increased when it is combined with Telithromycin.
Temsirolimus
The risk or severity of adverse effects can be increased when Apixaban is combined with Temsirolimus.
Tenecteplase
Tenecteplase may increase the anticoagulant activities of Apixaban.
Tenofovir Disoproxil
The metabolism of Apixaban can be decreased when combined with Tenofovir disoproxil.
Tenoxicam
Tenoxicam may increase the anticoagulant activities of Apixaban.
Teriflunomide
The serum concentration of Apixaban can be decreased when it is combined with Teriflunomide.
Testosterone Cypionate
The therapeutic efficacy of Apixaban can be increased when used in combination with Testosterone cypionate.
Testosterone Enanthate
The therapeutic efficacy of Apixaban can be increased when used in combination with Testosterone enanthate.
Testosterone Undecanoate
The therapeutic efficacy of Apixaban can be increased when used in combination with Testosterone undecanoate.
Theophylline
The metabolism of Apixaban can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Apixaban can be decreased when combined with Theophylline.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Apixaban.
Tiaprofenic Acid
Tiaprofenic acid may increase the anticoagulant activities of Apixaban.
Tibolone
Tibolone may increase the anticoagulant activities of Apixaban.
Ticagrelor
The risk or severity of adverse effects can be increased when Ticagrelor is combined with Apixaban.
Ticlopidine
The risk or severity of adverse effects can be increased when Ticlopidine is combined with Apixaban.
Tinzaparin
Tinzaparin may increase the anticoagulant activities of Apixaban.
Tinzaparin sodium
Tinzaparin may increase the anticoagulant activities of Apixaban.
Tipranavir
The serum concentration of Apixaban can be decreased when it is combined with Tipranavir.
Tirofiban
The risk or severity of adverse effects can be increased when Tirofiban is combined with Apixaban.
Tocilizumab
The serum concentration of Apixaban can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Apixaban can be decreased when combined with Tolbutamide.
Tolfenamic Acid
Tolfenamic Acid may increase the anticoagulant activities of Apixaban.
Tolmetin
Tolmetin may increase the anticoagulant activities of Apixaban.
Topiramate
The metabolism of Apixaban can be decreased when combined with Topiramate.
Tositumomab
The risk or severity of adverse effects can be increased when Apixaban is combined with Tositumomab.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Apixaban.
Tranylcypromine
The metabolism of Apixaban can be decreased when combined with Tranylcypromine.
Trapidil
The risk or severity of adverse effects can be increased when Trapidil is combined with Apixaban.
Treprostinil
Treprostinil may increase the anticoagulant activities of Apixaban.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Apixaban.
Triflusal
The risk or severity of adverse effects can be increased when Triflusal is combined with Apixaban.
Trimethoprim
The metabolism of Apixaban can be decreased when combined with Trimethoprim.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Apixaban.
Trolamine Salicylate
Trolamine salicylate may increase the anticoagulant activities of Apixaban.
Troxerutin
Apixaban may increase the anticoagulant activities of Troxerutin.
Urokinase
Urokinase may increase the anticoagulant activities of Apixaban.
Valdecoxib
Valdecoxib may increase the anticoagulant activities of Apixaban.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Apixaban.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Apixaban.
Valsartan
The metabolism of Apixaban can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Apixaban can be increased when it is combined with Vemurafenib.
Venlafaxine
The serum concentration of Apixaban can be increased when it is combined with Venlafaxine.
Verapamil
The serum concentration of Apixaban can be increased when it is combined with Verapamil.
Vitamin E
Vitamin E may increase the anticoagulant activities of Apixaban.
Vorapaxar
The risk or severity of adverse effects can be increased when Vorapaxar is combined with Apixaban.
Voriconazole
The serum concentration of Apixaban can be increased when it is combined with Voriconazole.
Warfarin
Apixaban may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Apixaban can be decreased when combined with Zafirlukast.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Apixaban.
Zileuton
Zileuton may increase the anticoagulant activities of Apixaban.
Ziprasidone
The serum concentration of Apixaban can be increased when it is combined with Ziprasidone.
Zomepirac
Zomepirac may increase the anticoagulant activities of Apixaban.
